Barbara Hill - Omega Healthcare Independent Director
| OHI Stock | USD 40.14 0.26 0.65% |
Director
Ms. Barbara B. Hill is an Independent Director of Omega Healthcare Investors, Inc., effective April 1, 2013. Ms. Hill brings to the Omega Board extensive experience in operating healthcarerelated companies. Ms. Hill is currently an Operating Partner of NexPhase Capital, a private equity firm, where she focuses on healthcarerelated investments and providing strategic and operating support for NexPhases healthcare portfolio companies. She began as an Operating Partner of Moelis Capital Partners in March 2011. From March 2006 to September 2010, Ms. Hill served as Chief Executive Officer and a director of ValueOptions, Inc., a managed behavioral health company, and FHC Health Systems, Inc., its parent company. From August 2004 to March 2006, she served as Chairman and Chief Executive Officer of Woodhaven Health Services, an institutional pharmacy company. In addition, from 2002 to 2003, Ms. Hill served as President and a director of Express Scripts, Inc., a pharmacy benefits management company. In previous positions, Ms. Hill was responsible for operations nationally for Cigna HealthCare, and also served as the Chief Executive Officer of health plans owned by Prudential, Aetna, and the Johns Hopkins Health System. She was also active with the boards or committees of the Association of Health Insurance Plans and other health insurance industry groups. Currently, she serves as a board member of Integra LifeSciences Holdings Corporationrationration, a medical device company and Owens Minor, Inc. a Fortune 500 healthcare logistics company. Ms. Hill was a member of the board of directors of St. Jude Medical Corporationrationration, from 2007 to January 2017 and Revera Inc., from 2010 to March 2017. since 2013.
| Age | 67 |
| Tenure | 11 years |
| Address | 303 International Circle, Hunt Valley, MD, United States, 21030-1394 |
| Phone | 410 427 1700 |
| Web | https://www.omegahealthcare.com |
Omega Healthcare Management Efficiency
The company has Return on Asset of 0.039 % which means that on every $100 spent on assets, it made $0.039 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0867 %, implying that it generated $0.0867 on every 100 dollars invested. Omega Healthcare's management efficiency ratios could be used to measure how well Omega Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to 0.03. The current Return On Capital Employed is estimated to decrease to 0.08. As of now, Omega Healthcare's Other Assets are increasing as compared to previous years. The Omega Healthcare's current Other Current Assets is estimated to increase to about 113 M, while Total Current Assets are projected to decrease to under 664.3 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Ronald Marston | Global Medical REIT | 78 | |
| Timothy Triche | LTC Properties | 75 | |
| Walter Rakowich | Ventas Inc | 63 | |
| James Morey | Universal Health Realty | 52 | |
| James Shelton | Ventas Inc | 66 | |
| Devra Shapiro | LTC Properties | 73 | |
| Peter Lyle | Healthcare Realty Trust | 56 | |
| Nancy Agee | Healthcare Realty Trust | 68 | |
| Colleen Schaller | National Health Investors | N/A | |
| Roscoe Moore | Global Medical REIT | 76 | |
| Robert Adams | National Health Investors | 74 | |
| Richard Gilchrist | Ventas Inc | 74 | |
| Paula Crowley | Global Medical REIT | 66 | |
| Cornelia Cheng | LTC Properties | 52 | |
| Peter Lyew | LTC Properties | 66 | |
| Roxanne Martino | Ventas Inc | 63 | |
| Boyd Hendrickson | LTC Properties | 75 | |
| Huiqi Zhang | Global Medical REIT | 31 | |
| Melody Barnes | Ventas Inc | 56 | |
| Christann Vasquez | Healthcare Realty Trust | 60 | |
| Bruce Sullivan | Healthcare Realty Trust | 79 | |
Management Performance
| Return On Equity | 0.0867 | ||||
| Return On Asset | 0.039 |
Omega Healthcare Inv Leadership Team
Elected by the shareholders, the Omega Healthcare's board of directors comprises two types of representatives: Omega Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Omega. The board's role is to monitor Omega Healthcare's management team and ensure that shareholders' interests are well served. Omega Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Omega Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Taylor CPA, CEO Director | ||
| Gail JD, Chief Counsel | ||
| Matthew Gourmand, IR Contact Officer | ||
| Kapila Anand, Independent Director | ||
| Neal Ballew, Senior Vice President Chief Accounting Officer | ||
| Burke Whitman, Independent Director | ||
| Edward Lowenthal, Independent Director | ||
| Craig Callen, Independent Chairman of the Board | ||
| Samuel Kovitz, Senior VP | ||
| C Pickett, Chief Executive Officer, Director | ||
| Daniel Booth, Chief Operating Officer | ||
| Kevin Jacobs, Independent Director | ||
| Megan Krull, Senior Operations | ||
| Michele Reber, Director Management | ||
| Robert Stephenson, Chief Financial Officer | ||
| Steven Insoft, Chief Corporate Development Officer | ||
| Michael Ritz, Chief Accounting Officer | ||
| Gail Makode, Chief Legal Officer, General Counsel | ||
| Stephen Plavin, Independent Director | ||
| Matthew CPA, Senior Relations | ||
| Barbara Hill, Independent Director | ||
| Lisa EgbuonuDavis, Director | ||
| Vikas Gupta, Senior Development |
Omega Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Omega Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0867 | ||||
| Return On Asset | 0.039 | ||||
| Profit Margin | 0.34 % | ||||
| Operating Margin | 0.66 % | ||||
| Current Valuation | 15.28 B | ||||
| Shares Outstanding | 269.95 M | ||||
| Shares Owned By Insiders | 0.28 % | ||||
| Shares Owned By Institutions | 73.55 % | ||||
| Number Of Shares Shorted | 8.39 M | ||||
| Price To Earning | 30.17 X |
Currently Active Assets on Macroaxis
When determining whether Omega Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Healthcare Investors Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Healthcare. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.137 | Dividend Share 2.68 | Earnings Share 1.36 | Revenue Per Share 4.03 | Quarterly Revenue Growth 0.14 |
The market value of Omega Healthcare Inv is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Omega Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Healthcare's market value can be influenced by many factors that don't directly affect Omega Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omega Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.